NDC Package 17772-121-10 Oxtellar Xr

Oxcarbazepine Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
17772-121-10
Package Description:
5 TABLET in 1 BLISTER PACK
Product Code:
Proprietary Name:
Oxtellar Xr
Non-Proprietary Name:
Oxcarbazepine
Substance Name:
Oxcarbazepine
Usage Information:
Oxcarbazepine is used with other medications to treat seizure disorders (epilepsy).
11-Digit NDC Billing Format:
17772012110
NDC to RxNorm Crosswalk:
  • RxCUI: 1365653 - OXcarbazepine 150 MG 24HR Extended Release Oral Tablet
  • RxCUI: 1365653 - 24 HR oxcarbazepine 150 MG Extended Release Oral Tablet
  • RxCUI: 1365653 - oxcarbazepine 150 MG 24 HR Extended Release Oral Tablet
  • RxCUI: 1365660 - Oxtellar XR 150 MG 24HR Extended Release Oral Tablet, Once-Daily
  • RxCUI: 1365660 - 24 HR oxcarbazepine 150 MG Extended Release Oral Tablet [Oxtellar]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Supernus Pharmaceuticals, Inc.
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    Yes
    FDA Application Number:
    NDA202810
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    01-17-2013
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    17772-121-01100 TABLET in 1 BOTTLE
    17772-121-077 TABLET in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 17772-121-10?

    The NDC Packaged Code 17772-121-10 is assigned to a package of 5 tablet in 1 blister pack of Oxtellar Xr, a human prescription drug labeled by Supernus Pharmaceuticals, Inc.. The product's dosage form is tablet and is administered via oral form.

    Is NDC 17772-121 included in the NDC Directory?

    Yes, Oxtellar Xr with product code 17772-121 is active and included in the NDC Directory. The product was first marketed by Supernus Pharmaceuticals, Inc. on January 17, 2013 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 17772-121-10?

    The 11-digit format is 17772012110. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-217772-121-105-4-217772-0121-10